<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430803</article-id><article-id pub-id-type="pmcid-ver">PMC12430803.1</article-id><article-id pub-id-type="pmcaid">12430803</article-id><article-id pub-id-type="pmcaiid">12430803</article-id><article-id pub-id-type="pmid">40540292</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002588</article-id><article-id pub-id-type="publisher-id">IJS-D-25-00794</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Systematic review and/or Meta-analysis</subject></subj-group></article-categories><title-group><article-title>The diagnostic accuracy of MRI radiomics in axillary lymph node metastasis prediction: a systematic review and meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Motiei</surname><given-names initials="M">Mahsa</given-names></name><email>Mahsa.motie764@gmail.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mansouri</surname><given-names initials="SS">Sahand Sadat</given-names></name><email>ssadatmansoory@gmail.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tamimi</surname><given-names initials="A">Amirhossein</given-names></name><email>amirhosseintamimi997@gmail.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Farokhi</surname><given-names initials="S">Simin</given-names></name><email>dr.siminfarokhi1310@gmail.com</email><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fakouri</surname><given-names initials="A">Arshia</given-names></name><email>arshiafk1376@gmail.com</email><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rassam</surname><given-names initials="K">Khoosheh</given-names></name><email>khoushehrassam@gmail.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sedighi-Pirsaraei</surname><given-names initials="N">Nasrin</given-names></name><email>nasrinsedighimd@gmail.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hassanzadeh-Rad</surname><given-names initials="A">Afagh</given-names></name><email>Afaghrad@gums.ac.ir</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>Pediatric Diseases Research Center, Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran</aff><aff id="aff2"><label>b</label>USERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding author. Address: Pediatric Diseases Research Center, Guilan University of Medical Sciences, Namjoo St., Shahid Siadati St., Rasht, Iran. Tel.: +9112334073. E-mail: <email>Afaghrad@gums.ac.ir</email> (A. Hassanzadeh-Rad).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>6</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>6412</fpage><lpage>6426</lpage><history><date date-type="received"><day>08</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>16</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-Non Commercial License 4.0</ext-link> (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-6412.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-6412.pdf"/><abstract><sec><title>Background:</title><p>Breast cancer is the most prevalent malignancy in women and a leading cause of mortality. Accurate assessment of axillary lymph node metastasis (LNM) is critical for breast cancer management. Exploring non-invasive methods such as radiomics for the detection of LNM is highly important.</p></sec><sec><title>Methods:</title><p>We systematically searched PubMed, Embase, Scopus, Web of Science and google scholar until 11 March 2024. To assess the risk of bias and quality of studies, we utilized the quality assessment of diagnostic accuracy studies (QUADAS) tool as well as the radiomics quality score (RQS). Area under the curve (AUC), sensitivity, specificity and accuracy were determined for each study to evaluate the diagnostic accuracy of radiomics in magnetic resonance imaging (MRI) for detecting LNM in patients with breast cancer.</p></sec><sec><title>Results:</title><p>This meta-analysis of 20 studies (5072 patients) demonstrated an overall AUC of 0.83 (95% confidence interval (CI): 0.80&#8211;0.86). Subgroup analysis revealed a trend toward higher specificity when radiomics was combined with clinical factors (0.83) compared to radiomics alone (0.79). Sensitivity analysis confirmed the robustness of the findings and publication bias was not evident. The radiomics models increased the likelihood of a positive LNM outcome from 37% to 73.2% when initial probability was positive and decreased the likelihood to 8% when initial probability was negative, highlighting their potential clinical utility.</p></sec><sec><title>Conclusion:</title><p>Radiomics as a non-invasive method demonstrates strong potential for detecting LNM in breast cancer, offering clinical promise. However, further standardization and validation are needed in future studies.</p></sec></abstract><kwd-group><kwd>artificial intelligence</kwd><kwd>breast neoplasms</kwd><kwd>lymph node metastasis</kwd><kwd>meta-analysis</kwd><kwd>radiomics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Breast cancer in women is recognized as the most common malignant tumor with the highest mortality rate in the world<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup>. Also, it is estimated that the incidence of breast cancer would have an increasing rate from 1990 to 2030<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup>. Axillary lymph nodes are in the metastatic route of breast tumors and their status can determine the prognosis and treatment plan of patients with breast cancer<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup>. The gold standard of diagnosing lymph node metastasis (LNM) is pathological assessment of specimens obtained through Axillary lymph node dissection and sentinel lymph node biopsy which are invasive procedures associated with complications such as lymphedema, sensory problems and impaired mobility. In sentinel lymph node biopsy, complication rates have been reported to reach up to 41%<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup>. Moreover, the false negative rate of biopsies has been reported to be as high as 70% in some studies<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>]</sup>.<boxed-text id="UBT0001" position="float" orientation="portrait"><sec><title>HIGHLIGHTS</title><p>
<list list-type="bullet"><list-item><p>Radiomics models demonstrated good diagnostic performance for predicting lymph node metastasis (LNM) in breast cancer, yielding an AUC of 0.83.</p></list-item><list-item><p>Incorporating clinical factors alongside radiomics improved specificity (0.83) while slightly reducing sensitivity (0.74) compared to radiomics-only models.</p></list-item><list-item><p>Studies using 1.5 Tesla MRI showed significantly higher sensitivity (0.86) than those using 3 Tesla MRI (0.72).</p></list-item><list-item><p>The use of radiomics models considerably impacted clinical likelihood estimates for LNM, increasing the probability of a positive diagnosis from 37% to 73.2% when the initial assessment was positive, and decreasing it to 8% when the initial assessment was negative, indicating a negative likelihood ratio of 0.36.</p></list-item></list></p></sec></boxed-text></p><p>Therefore, non-invasive methods for assessing the status of axillary lymph nodes are highly needed in clinical practice. At first, Gillies expressed the application of image omics for extracting features and providing a database of image characteristics for diagnosis and treatment of diseases<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup>.</p><p>Recently, artificial intelligence has emerged as a valuable asset in both research and clinical settings<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup>. Radiomics utilizes artificial intelligence to develop models of quantitative features extracted from images of confirmed cases with the ability of predicting the disease<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup>. While direct image interpretation for diagnosis can be biased by the radiologist&#8217;s expertise, radiomics addresses this limitation by converting medical images into reproducible and quantitative data<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup>. On the other hand, magnetic resonance imaging (MRI) is the best imaging method for comprehensive evaluation of tumor and axillary lymph nodes in patients with breast cancer. It shows more area in the axilla than mammography, is not operator-dependent like sonography, and is not as expensive as PET-CT<sup>[<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref>]</sup>.</p><p>Acknowledging the significance of exploring non-invasive diagnostic methods to improve breast cancer management, this systematic review and meta-analysis aimed to assess the diagnostic performance of MRI radiomics models in identifying LNM in patients with breast cancer.</p></sec><sec sec-type="methods"><title>Materials and methods</title><sec><title>Study protocol and registration</title><p>Current study has prepared in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> guidelines. The study has been reported in line with AMSTAR (Assessing the methodological quality of systematic reviews) Guidelines<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup> and was registered in Prospective Register of Systematic Reviews (PROSPERO).</p></sec><sec><title>Literature search</title><p>Two authors searched the electronic databases of the PubMed, Embase, Scopus, Web of Science and google scholar to find the relevant articles, independently (medical doctors). In case of any disagreement, they resolved the issue by discussing it with a third reviewer (radiologist with 25&#160;years of experience in breast cancer imaging). The searching process was updated on 11 March 2024, and the following keywords and their equivalents were used for searching: &#8220;breast cancer,&#8221; &#8220;magnetic resonance imaging,&#8221; &#8220;radiomic,&#8221; &#8220;lymphatic metastasis.&#8221; MeSH terms and variations of each term were used. Only studies published in English were considered and all references extracted from databases were managed in Endnote software, version X8.</p><p>We assessed all papers to find and remove duplicates. After eliminating the duplicate papers, we reviewed the title and abstract of all articles and removed those that did not meet our inclusion criteria. Then, the complete texts of all remained articles were reviewed. Also, we reviewed the reference lists of articles and previous relevant reviews to find further related articles. If multiple papers were published using the same case set, the one with highest number of cases and the most comprehensive details was selected for inclusion.</p><p>The inclusion criteria were:
<list list-type="order"><list-item><p>Original research articles</p></list-item><list-item><p>Studies involving patients with breast cancer diagnosed through biopsy or surgical excision, where LNM was assessed through sentinel lymph node biopsy or axillary lymph node dissection</p></list-item><list-item><p>Studies that included MRI imaging of patients prior to surgery, with a radiomics assessment</p></list-item><list-item><p>Studies that provided sufficient information to determine the sensitivity and specificity of LNM diagnosis</p></list-item></list></p><p>The exclusion criteria were as follows:
<list list-type="order"><list-item><p>Animal experiments, non-diagnostic tests, case reports, abstracts of conferences, reviews and editorial articles.</p></list-item><list-item><p>Studies lacking sufficient pathological data to diagnose metastasis</p></list-item><list-item><p>Studies on patients who received pre-operative treatments including radiotherapy and chemotherapy</p></list-item></list></p></sec><sec><title>Data extraction</title><p>Two authors did the data extraction and quality assessment, independently (medical doctors). In case of any discrepancies, resolved them by a third author (medical doctor).</p><p>The following data were extracted from each study including the first author, publication year, study design, country, Number of patients, tesla of MRI, contrast agent, dynamic phase protocol, scanner brand, dynamic contrast enhanced (DCE), segmentation method, platform of feature extraction, feature selection method, classification method, combined clinical, external validation, the area under the curve (AUC), sensitivity, specificity, accuracy (ACC), true positive (TP), true negative (TN), false positive (FP), false negative (FN), positive LNM in training and validation groups, number of patients in training and validation groups and the grade of breast cancer. In case of testing different models on a patient group, we reported the result of the model with the highest AUC.</p></sec><sec><title>Quality assessment</title><p>The quality assessment of diagnostic accuracy studies-2 (QUADAS-2) tool was utilized to assess the quality of included papers. The details of questions are presented in Fig. <xref rid="F2" ref-type="fig">2</xref>. Also, the methodological quality of studies was assessed by using the radiomics quality score (RQS) tool which was introduced by Lambin <italic toggle="yes">et al</italic> for the first time<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup>.</p></sec><sec><title>Statistical analysis</title><p>Statistical analyses for this study were performed using the mada, metafor, and meta packages in R, as well as the midas modules in Stata 14.0 (StataCorp LLC, College Station, Texas, USA), along with OpenMetaAnalyst software<sup>[<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref>]</sup>. We calculated cumulative values for sensitivity (SENS), specificity (SPEC), diagnostic odds ratio<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup>, positive likelihood ratio (PLR), and negative likelihood ratio (NLR), along with their corresponding 95% confidence intervals (CIs). Additionally, we constructed the summary receiver operating characteristic (SROC) curve and the area under the curve (AUC) using a random effects model to assess the diagnostic performance of the combined studies<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup>. Coupled forest plots were created to visually represent pooled sensitivity and specificity. In the subgroup analysis, we examined specific covariates to identify sources of heterogeneity. These included study design (retrospective vs. prospective), the use of DCE-MRI and 1.5 or 3 Tesla magnetic resonance imaging, integration of clinical data with radiomics, feature extraction platforms, feature selection methods, and the types of classifiers used (Logistic Regression (LR), Support Vector Machine (SVM), or other classifiers). Cochran&#8217;s Q test and Higgins&#8217; I<sup>2</sup> statistic were calculated to estimate heterogeneity among the studies included in this meta-analysis. A <italic toggle="yes">P</italic> value of less than 0.05 was considered significant, with heterogeneity categorized as follows: 0 to 25% indicating very low heterogeneity, 25 to 50% indicating low heterogeneity, 50 to 75% indicating medium heterogeneity, and greater than 75% indicating high heterogeneity. To evaluate the impact of individual studies on the overall estimate, sensitivity analyses were conducted by sequentially excluding one study at a time from the meta-analysis calculations. Deeks&#8217; funnel plot asymmetry test was utilized to assess publication bias, while Egger&#8217;s test provided a quantitative evaluation of this risk. Statistical significance was defined as <italic toggle="yes">P</italic> &lt;0.05. The pooling of studies and effect sizes were assessed using a random-effects model, which accommodates the distribution of true effects across heterogeneous studies. Furthermore, the Fagan nomogram was employed to evaluate the clinical applicability of the radiomics models by comparing changes in post-test probabilities to the original pre-test probabilities.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Literature search</title><p>Our systematic literature search yielded 723 initial records. After removing 270 duplicates, we screened 453 citations. Reviewing the title and abstract of articles resulted in the exclusion of 367 studies. Full-text assessment of the remaining articles led to 47 more exclusions. This selection process ultimately yielded 20 eligible studies for inclusion in the final meta-analysis. Our selection workflow is demonstrated in Fig. <xref rid="F1" ref-type="fig">1</xref>.<fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>Flow diagram representing the literature search process.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6412-g001.jpg"/></fig>
</p></sec><sec><title>Study characteristics</title><p>We included 20 studies from 2019 to 2024, including a total number of 5072 patients. Characteristics of the selected studies are presented in Table<xref rid="T1" ref-type="table">1</xref>. Just one of the studies was designed prospectively<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> and the other 19 studies were designed retrospectively. The majority of the studies (18/20) were conducted in China, one was conducted in USA<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup>, and one in Italy<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup>. 9 studies combined radiomics with clinical parameters<sup>[<xref rid="R22" ref-type="bibr">22</xref>-<xref rid="R30" ref-type="bibr">30</xref>]</sup>. 15 Studies used manual segmentation<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R25" ref-type="bibr">25</xref>-<xref rid="R35" ref-type="bibr">35</xref>]</sup>, one study used automatic<sup>[<xref rid="R36" ref-type="bibr">36</xref>]</sup> and four used semi-automatic segmentation<sup>[<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R37" ref-type="bibr">37</xref>]</sup>. Most studies included in our review used Pyradiomics software to extract radiomics features (8/20)<sup>[<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref>]</sup>. Four studies used MatLab<sup>[<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R35" ref-type="bibr">35</xref>]</sup> and one study reported that they used either MatLab or LIFEx for feature extraction<sup>[<xref rid="R26" ref-type="bibr">26</xref>]</sup>. Other utilized software was Densely Connected Convolutional Networks (DenseNet) 121 in the framework of Keras 2.0.5<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup>, AK software (Artificial intelligence kit)<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup>, Darwin Scientific Research Platform<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup>, MR Radiomics Platform (MRP)<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup> and RadCloud Platform<sup>[<xref rid="R30" ref-type="bibr">30</xref>]</sup>. LASSO was the most frequent method used for feature selection (15/20)<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R24" ref-type="bibr">24</xref>-<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R32" ref-type="bibr">32</xref>-<xref rid="R37" ref-type="bibr">37</xref>]</sup>. The classification methods used in the studies were LR (11/20)<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R24" ref-type="bibr">24</xref>-<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R33" ref-type="bibr">33</xref>-<xref rid="R35" ref-type="bibr">35</xref>]</sup>, SVM (5/20)<sup>[<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R37" ref-type="bibr">37</xref>]</sup>, LDA (1/20)<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup>, RF (2/20)<sup>[<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R29" ref-type="bibr">29</xref>]</sup> and CNN (1/20)<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup>. A study used a combination of multiple classification methods including LASSO, RF, SVM, DT, LR and Boosting methods<sup>[<xref rid="R36" ref-type="bibr">36</xref>]</sup>. Furthermore, 9/20 studies combined clinical factors with radiomics features to construct the model<sup>[<xref rid="R22" ref-type="bibr">22</xref>-<xref rid="R30" ref-type="bibr">30</xref>]</sup>.<table-wrap position="float" id="T1" orientation="landscape"><label>Table 1</label><caption><p>Study population characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="left" rowspan="1" colspan="1">Year</th><th align="left" rowspan="1" colspan="1">Design</th><th align="left" rowspan="1" colspan="1">Country</th><th align="left" rowspan="1" colspan="1">Number of patients</th><th align="left" rowspan="1" colspan="1">DCE</th><th align="left" rowspan="1" colspan="1">Tesla of MRI</th><th align="left" rowspan="1" colspan="1">MRI contrast agent</th><th align="left" rowspan="1" colspan="1">MRI dynamic phase protocol</th><th align="left" rowspan="1" colspan="1">Scanner brand</th><th align="left" rowspan="1" colspan="1">Segmentation</th><th align="left" rowspan="1" colspan="1">Platform for feature extraction</th><th align="left" rowspan="1" colspan="1">Feature selection method</th><th align="left" rowspan="1" colspan="1">Classification</th><th align="left" rowspan="1" colspan="1">Combined clinical parameters</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Jia Liu</td><td align="center" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">Prospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Gd-DTPA (0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">5-phase dynamic (40s delay, 58s per phase)</td><td align="left" rowspan="1" colspan="1">GE Discovery MR750</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Radcloud platform</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Lu Han</td><td align="center" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">411</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">Gd-DTPA-MBA (Omniscan, 0.1&#160;mmol/kg @ 3&#160;mL/s)</td><td align="left" rowspan="1" colspan="1">8-phase dynamic (continuous, 43s per phase, total 5.7&#160;min)</td><td align="left" rowspan="1" colspan="1">HDx, GE Healthcare</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">SVM</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Chunling Liu</td><td align="center" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">163</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">Magnevist (0.2&#160;ml/kg @ 2&#160;ml/s)</td><td align="left" rowspan="1" colspan="1">5-phase dynamic (1 pre-, 4 post-contrast, 2&#160;ml/s injection, 20&#160;ml saline flush)</td><td align="left" rowspan="1" colspan="1">GE Signa HDxt</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">LIFEx or MatLab</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Hongna Tan</td><td align="center" rowspan="1" colspan="1">2019</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">329</td><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8-phase dynamic (1 pre-, 7 post-contrast, 20&#160;ml saline flush)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">MATLAB</td><td align="left" rowspan="1" colspan="1">Mann&#8211;Whitney U-test&#160;+&#160;SVM</td><td align="left" rowspan="1" colspan="1">SVM</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Dooman Arefan</td><td align="center" rowspan="1" colspan="1">2020</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">154</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Magnevist (0.2&#160;ml/kg)</td><td align="left" rowspan="1" colspan="1">8-phase dynamic (1 pre-, 7 post-contrast, 60s per phase, saline flush)</td><td align="left" rowspan="1" colspan="1">Siemens Magnetom Verio</td><td align="left" rowspan="1" colspan="1">Semi-automatic</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">LDA</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Meijie Liu</td><td align="center" rowspan="1" colspan="1">2020</td><td align="left" rowspan="1" colspan="1">Prospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">164</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Omniscan (0.2&#160;mmol/kg</td><td align="left" rowspan="1" colspan="1">30-phase dynamic (1 pre-, 29 post-contrast, 16s per phase, saline flush)</td><td align="left" rowspan="1" colspan="1">GE Discovery 750&#160;W</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Artificial Intelligence Kit</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Yadi Zhu</td><td align="center" rowspan="1" colspan="1">2021</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">177</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Gd-DTPA-MBA (0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">5-phase dynamic (1 pre-, 4 post-contrast, 61s per phase, 15&#160;ml saline flush)</td><td align="left" rowspan="1" colspan="1">GE Discovery 750&#160;W</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Darwin Scientific Research Platform</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">SVM</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Domiziana Santucci</td><td align="center" rowspan="1" colspan="1">2021</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">Italy</td><td align="center" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Gadobenate dimeglumine (0.2&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">6-phase dynamic (1 pre-, 5 post-contrast, unspecified timing for phases)</td><td align="left" rowspan="1" colspan="1">GE Discovery 750</td><td align="left" rowspan="1" colspan="1">Semi-automatic</td><td align="left" rowspan="1" colspan="1">MATLAB</td><td align="left" rowspan="1" colspan="1">Wrapper</td><td align="left" rowspan="1" colspan="1">RF</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Huifang Chen</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">111</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Hengrui (0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">8-phase dynamic (1 pre-, 7 post-contrast, unspecified timing for phases)</td><td align="left" rowspan="1" colspan="1">Philips Ingenia</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">Student&#8217;s t test or the Mann&#8211;Whitney U test&#160;+&#160;Spearman correlation analysis</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Danxiang Chen</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">243</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Gd-DTPA (0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">5-phase dynamic (90 s per phase)</td><td align="left" rowspan="1" colspan="1">GE Healthcare SIGNA HDx 3.0&#160;T</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">MATLAB</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Yuan Cheng</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">208</td><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HDx, GE Healthcare</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Deling Song</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">432</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Omniscan (Gd-DTPA, 0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">9-phase dynamic (1 pre-contrast, 8 post-contrast, 58 s per phase)</td><td align="left" rowspan="1" colspan="1">Philips 3.0 T (Philips Healthcare)</td><td align="left" rowspan="1" colspan="1">Semi-automatic</td><td align="left" rowspan="1" colspan="1">MR Radiomics Platform (MRP)</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Ying Liu</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">312</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Gd-DTPA (0.2&#160;mL/kg)</td><td align="left" rowspan="1" colspan="1">8-phase dynamic (1 pre-contrast, 7 post-contrast, 1&#160;min per phase)</td><td align="left" rowspan="1" colspan="1">Siemens Verio Tim 3.0&#160;T</td><td align="left" rowspan="1" colspan="1">Semi-automatic</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">SVM</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Dawei Wang</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">151</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Omniscan (0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Siemens Skyra (3.0&#160;T)</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">LightGBM</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Mingming Ma</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">142</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Magnevist (Gd-DTPA, 0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">9-phase dynamic (1 pre-, 8 post-contrast); 58 s per phase; 3rd post-contrast used</td><td align="left" rowspan="1" colspan="1">GE Signa Excite 3.0&#160;T</td><td align="left" rowspan="1" colspan="1">Automatic</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">A combination of 10 methods including LASSO, RF, SVM, DT, LR, Boosting methods)</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Xiaoming Qiu</td><td align="center" rowspan="1" colspan="1">2022</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Siemens 1.5&#160;T superconducting</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Pyradiomics</td><td align="left" rowspan="1" colspan="1">LASSO&#160;+&#160;Wrapper</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Yanhong Chen</td><td align="center" rowspan="1" colspan="1">2023</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">479</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Gd-DTPA (0.1&#160;mmol/kg, Beilu)</td><td align="left" rowspan="1" colspan="1">5-phase dynamic (1 pre-, 4 post-contrast); unspecified timing</td><td align="left" rowspan="1" colspan="1">Philips Ingenia 3.0&#160;T</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Python Keras Library</td><td align="left" rowspan="1" colspan="1">LASSO&#160;+&#160;Wrapper</td><td align="left" rowspan="1" colspan="1">LR</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">MingzhenChen</td><td align="center" rowspan="1" colspan="1">2023</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">988</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CNN</td><td align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Jian Wang</td><td align="center" rowspan="1" colspan="1">2023</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">172</td><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Philips Achieva 1.5&#160;T</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">MATLAB</td><td align="left" rowspan="1" colspan="1">Wrapper</td><td align="left" rowspan="1" colspan="1">RF</td><td align="left" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Yusi Chen</td><td align="center" rowspan="1" colspan="1">2024</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">177</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Gd-DTPA (0.1&#160;mmol/kg)</td><td align="left" rowspan="1" colspan="1">9-phase dynamic (1 pre-, 8 post-contrast); 80 s per phase; all phases used</td><td align="left" rowspan="1" colspan="1">GE Discovery MR750w 3.0&#160;T</td><td align="left" rowspan="1" colspan="1">Manual</td><td align="left" rowspan="1" colspan="1">Radcloud platform</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="left" rowspan="1" colspan="1">SVM</td><td align="left" rowspan="1" colspan="1">Yes</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">External validation</th><th align="left" rowspan="1" colspan="1">AUC</th><th align="left" rowspan="1" colspan="1">Sensitivity</th><th align="left" rowspan="1" colspan="1">Specificity</th><th align="left" rowspan="1" colspan="1">ACC</th><th align="left" rowspan="1" colspan="1">TP<xref rid="tbl1-fn1" ref-type="table-fn">a</xref></th><th align="left" rowspan="1" colspan="1">FP<xref rid="tbl1-fn1" ref-type="table-fn">a</xref></th><th align="left" rowspan="1" colspan="1">TN<xref rid="tbl1-fn1" ref-type="table-fn">a</xref></th><th align="left" rowspan="1" colspan="1">FN<xref rid="tbl1-fn1" ref-type="table-fn">a</xref></th><th align="left" rowspan="1" colspan="1">Positive LNM in training group</th><th align="left" rowspan="1" colspan="1">Number of patients in training group</th><th align="left" rowspan="1" colspan="1">Positive LNM in validation group</th><th align="left" rowspan="1" colspan="1">Number of patients in validation group</th><th align="left" rowspan="1" colspan="1">Grade1</th><th align="left" rowspan="1" colspan="1">Grade2</th><th align="left" rowspan="1" colspan="1">Grade3</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.88</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">0.77</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.85</td><td align="center" rowspan="1" colspan="1">0.80</td><td align="center" rowspan="1" colspan="1">82</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">97</td><td align="center" rowspan="1" colspan="1">279</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">132</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.869</td><td align="center" rowspan="1" colspan="1">0.77</td><td align="center" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">109</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">45</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">0.60</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">78.33</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">269</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">223</td><td align="center" rowspan="1" colspan="1">86</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.82</td><td align="center" rowspan="1" colspan="1">0.82</td><td align="center" rowspan="1" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">103</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.76</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">0.76</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">61</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.88</td><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1">0.9</td><td align="center" rowspan="1" colspan="1">0.8</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">177</td><td align="center" rowspan="1" colspan="1">95</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.856</td><td align="center" rowspan="1" colspan="1">0.85</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.828</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">0.57</td><td align="center" rowspan="1" colspan="1">53</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">84</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.85</td><td align="center" rowspan="1" colspan="1">0.64</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">160</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">83</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">138</td><td align="center" rowspan="1" colspan="1">84</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.802</td><td align="center" rowspan="1" colspan="1">0.84</td><td align="center" rowspan="1" colspan="1">0.67</td><td align="center" rowspan="1" colspan="1">0.757</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">138</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">169</td><td align="center" rowspan="1" colspan="1">35</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.867</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.80</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">106</td><td align="center" rowspan="1" colspan="1">296</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">136</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">257</td><td align="center" rowspan="1" colspan="1">83</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.775</td><td align="center" rowspan="1" colspan="1">0.95</td><td align="center" rowspan="1" colspan="1">0.55</td><td align="center" rowspan="1" colspan="1">0.677</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">98</td><td align="center" rowspan="1" colspan="1">250</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">0.75</td><td align="center" rowspan="1" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">106</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.906</td><td align="center" rowspan="1" colspan="1">0.86</td><td align="center" rowspan="1" colspan="1">0.85</td><td align="center" rowspan="1" colspan="1">0.857</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.793</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.603</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">54</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">0.65</td><td align="center" rowspan="1" colspan="1">0.8</td><td align="center" rowspan="1" colspan="1">0.71</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">123</td><td align="center" rowspan="1" colspan="1">366</td><td align="center" rowspan="1" colspan="1">44</td><td align="center" rowspan="1" colspan="1">122</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">40</td></tr><tr><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">0.759</td><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">79.7</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">82</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">519</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">129</td><td align="center" rowspan="1" colspan="1">76</td><td align="center" rowspan="1" colspan="1">512</td><td align="center" rowspan="1" colspan="1">400</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">400</td><td align="center" rowspan="1" colspan="1">77</td><td align="center" rowspan="1" colspan="1">223</td><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">62</td><td align="center" rowspan="1" colspan="1">67</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">0.9</td><td align="center" rowspan="1" colspan="1">0.76</td><td align="center" rowspan="1" colspan="1">0.88</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">143</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>ACC: accuracy, AUC: area under curve, DCE: dynamic contrast-enhanced, FP: false positive, FN: false negative, LNM: lymph node metastasis, MRI: magnetic resonance imaging, TN: true negative, TP: true positive</p></fn><fn id="tbl1-fn1"><label><sup>a</sup></label><p>Manually calculated</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec><title>Data quality assessment</title><p>We assessed the quality of the selected studies using QUADAS-2 tool as illustrated in Fig. <xref rid="F2" ref-type="fig">2</xref>. In general, th111h risk of bias and another study (5%) did not provide enough information regarding the patient selection process. In the index test domain, all studies exhibited a low risk of bias, except for two that lacked sufficient information (10%). The Reference standard domain was clearly indicated in 18 studies (90%), while two studies (10%) mentioned it without adequate detail. Regarding the flow and timing domain, 12 studies (60%) reported insufficient information about the interval between performing radiomics analysis and the reference standard.<fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>The quality assessment of diagnostic accuracy studies-2 (QUADAS-2).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6412-g002.jpg"/></fig>
</p><p>We assessed the quality of all studies in utilizing radiomics by RQS checklist presenting in Table <xref rid="T2" ref-type="table">2</xref>, in 16 domains showed an overall quality of 45.5%. None of the studies performed Phantom studies, two of the studies performed cost-effectiveness analyses, 18 of 20 studies were retrospective and two were prospective. Comparing quality between the two subgroups of MRI magnetic field strengths showed that mean RQS in studies using 1.5 Tesla<sup>[<xref rid="R25" ref-type="bibr">25</xref>-<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R34" ref-type="bibr">34</xref>]</sup> were similar with those applying 3 Tesla MRI (mean&#160;=18 for both subgroups)<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R32" ref-type="bibr">32</xref>,<xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R38" ref-type="bibr">38</xref>]</sup>.<table-wrap position="float" id="T2" orientation="landscape"><label>Table 2</label><caption><p>Radiomics quality score (RQS) of the included studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">References</th><th align="left" rowspan="1" colspan="1">Image protocol (0-2)</th><th align="left" rowspan="1" colspan="1">Multiple segmentations (0-1)</th><th align="left" rowspan="1" colspan="1">Phantom study (0-1)</th><th align="left" rowspan="1" colspan="1">Multiple timepoints (0-1)</th><th align="left" rowspan="1" colspan="1">Feature reduction(&#8722;3 to 3)</th><th align="left" rowspan="1" colspan="1">Nonradiomics (0-1)</th><th align="left" rowspan="1" colspan="1">Biological correlates (0-1)</th><th align="left" rowspan="1" colspan="1">Cut-off(0-1)</th><th align="left" rowspan="1" colspan="1">Discrimination/resampling (0-2)</th><th align="left" rowspan="1" colspan="1">Calibration/resampling (0-2)</th><th align="left" rowspan="1" colspan="1">Prospective (0-7)</th><th align="left" rowspan="1" colspan="1">Validation (&#8722;5 to 5)</th><th align="left" rowspan="1" colspan="1">Gold standard (0-2)</th><th align="left" rowspan="1" colspan="1">Clinical utility (0-2)</th><th align="left" rowspan="1" colspan="1">Cost (0-1)</th><th align="left" rowspan="1" colspan="1">Open science (0-4)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Deling Song</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Danxiang Chen</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Jian Wang</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Arefan Dooman</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Dawei Wang</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Domiziana Santucci</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Huifang Chen</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Chunling Liu</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Jia Liu</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Hongna Tan</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Lu Han et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Mingming Ma et al.</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Mingzhen Chen et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Meijie Liu et al.</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Xiaoming Qiu et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Yadi Zhu et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Yanhong Chen et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Ying Liu et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Yuan Cheng et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Yusi Chen et al.</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr></tbody></table></table-wrap>
</p></sec><sec><title>Data analysis</title><p>The overall radiomics models showed good diagnostic performance in predicting LNM in patients with breast cancer, with an AUC of 0.83 (95% CI: 0.80, 0.86), a sensitivity of 0.78 (95% CI: 0.68, 0.85, I<sup>2</sup>&#160;=&#160;86.99) and a specificity of 0.81 (95% CI: 0.78, 0.84, I<sup>2</sup>&#160;=&#160;36.43). The forest plot of pooled sensitivity and specificity is illustrated in Fig. <xref rid="F3" ref-type="fig">3</xref>. The SROC curve of all studies is presented in Fig. <xref rid="F4" ref-type="fig">4</xref>, indicating an AUC of 0.83 (95% CI, 0.80&#8211;0.86). Furthermore, the ROC plane is shown in Fig. <xref rid="F5" ref-type="fig">5</xref>.<fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><p>Forest plots of radiomics&#8217; sensitivity and specificity in patients with breast cancer.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6412-g003.jpg"/></fig>
<fig position="float" id="F4" orientation="portrait"><label>Figure 4.</label><caption><p>Summary receiver operating characteristics (SROC) curve of radiomics in diagnosis of lymph node metastasis of patients with breast cancer.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6412-g004.jpg"/></fig>
<fig position="float" id="F5" orientation="portrait"><label>Figure 5.</label><caption><p>ROC plane of the included studies.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6412-g005.jpg"/></fig>
</p></sec><sec><title>Subgroup analysis</title><p>The I<sup>2</sup> statistic reveals significant heterogeneity in sensitivity (I<sup>2</sup>&#160;=&#160;86.99%) and moderate heterogeneity in specificity (I<sup>2</sup>&#160;=&#160;36.43%), suggesting that the results vary considerably for sensitivity while indicating more consistency for specificity. We performed subgroup analysis to identify the reasons of heterogeneity. Regarding the design of the studies, radiomics models had no significant difference in retrospective (sensitivity,0.87 [95% CI, 0.65&#8211;0.83]; specificity, 0.82 [95% CI, 0.78&#8211;0.86.]), and prospective designs (sensitivity,0.73 [95% CI, 0.56&#8211;0.90]; specificity, 0.81 [95% CI, 0.66&#8211;0.96.]). Studies with combined radiomics and clinical factors (n&#160;=&#160;9) reached higher specificity 0.83 (95% CI, 0.80&#8211;0.86) and a slightly lower sensitivity 0.74 (95% CI, 0.69&#8211;0.79) compared to studies with only radiomics models (n&#160;=&#160;11) (sensitivity,0.76 [95% CI, 0.65&#8211;0.87]; specificity, 0.79 [95% CI, 0.73&#8211;0.86]) DCE-MRI studies compared to those without contrast agent had higher specificity 0.83 (95% CI, 0.80&#8211;0.86) versus 0.80 (95% CI, 0.70&#8211;0.91) and lower sensitivity 0.74 (95% CI, 0.68&#8211;0.79) versus 0.82 (95% CI, 0.64&#8211;0.99). The tesla of MRI imaging was the only variable that showed significant difference in sensitivity (<italic toggle="yes">P</italic> =&#160;0.03). Studies utilizing 1.5 Tesla MRI (n&#160;=&#160;5) showed higher sensitivity compared to those with 3 Tesla (n&#160;=&#160;14) (sensitivities of 0.86 and 0.72, respectively) (Table <xref rid="T3" ref-type="table">3</xref>).<table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><p>The results of subgroup analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1">Subgroups</th><th align="left" rowspan="1" colspan="1">No. of studies</th><th align="left" rowspan="1" colspan="1">Sensitivity</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th><th align="left" rowspan="1" colspan="1">Specificity</th><th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td rowspan="2" align="left" colspan="1">Study design</td><td align="left" rowspan="1" colspan="1">Retrospective</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">0.74 (0.65&#8211;0.83)</td><td rowspan="2" align="center" colspan="1">0.87</td><td align="center" rowspan="1" colspan="1">0.82 (0.78&#8211;0.86)</td><td rowspan="2" align="center" colspan="1">0.91</td></tr><tr><td align="left" rowspan="1" colspan="1">Prospective</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.73 (0.56&#8211;0.90)</td><td align="center" rowspan="1" colspan="1">0.81 (0.66&#8211;0.96)</td></tr><tr><td rowspan="2" align="left" colspan="1">DCE-MRI</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">0.74 (0.68&#8211;0.79)</td><td rowspan="2" align="center" colspan="1">0.38</td><td align="center" rowspan="1" colspan="1">0.83 (0.80&#8211;0.86)</td><td rowspan="2" align="center" colspan="1">0.69</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0.82 (0.64&#8211;0.99)</td><td align="center" rowspan="1" colspan="1">0.80 (0.70&#8211;0.91)</td></tr><tr><td rowspan="2" align="left" colspan="1">Tesla of MRI</td><td align="left" rowspan="1" colspan="1">1.5 Tesla</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">0.86 (0.74&#8211;0.97)</td><td rowspan="2" align="center" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">0.79 (0.72&#8211;0.87)</td><td rowspan="2" align="center" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">3 Tesla</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">0.72 (0.65&#8211;0.78)</td><td align="center" rowspan="1" colspan="1">0.84 (0.80&#8211;0.88)</td></tr><tr><td rowspan="4" align="left" colspan="1">Feature extraction</td><td align="left" rowspan="1" colspan="1">Radcloud platform</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">0.75 (0.59&#8211;0.91)</td><td rowspan="4" align="center" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1">0.87 (0.76&#8211;0.97)</td><td rowspan="4" align="center" colspan="1">0.85</td></tr><tr><td align="left" rowspan="1" colspan="1">Pyradiomics platform</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0.75 (0.67&#8211;0.84)</td><td align="center" rowspan="1" colspan="1">0.81 (0.74&#8211;0.88)</td></tr><tr><td align="left" rowspan="1" colspan="1">MATLAB platform</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0.79 (0.63&#8211;0.96)</td><td align="center" rowspan="1" colspan="1">0.82 (0.72&#8211;0.92)</td></tr><tr><td align="left" rowspan="1" colspan="1">Other Platforms</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">0.72 (0.65&#8211;0.79)</td><td align="center" rowspan="1" colspan="1">0.82 (0.78&#8211;0.87)</td></tr><tr><td rowspan="2" align="left" colspan="1">Feature selection method</td><td align="left" rowspan="1" colspan="1">LASSO</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">0.75 (0.70&#8211;0.80)</td><td rowspan="2" align="center" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">0.83 (0.80&#8211;0.87)</td><td rowspan="2" align="center" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Other</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0.78 (0.61&#8211;0.95)</td><td align="center" rowspan="1" colspan="1">0.76 (0.65&#8211;0.87)</td></tr><tr><td rowspan="2" align="left" colspan="1">Combined with clinical factors</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">0.74 (0.69&#8211;0.79)</td><td rowspan="2" align="center" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">0.83 (0.80&#8211;0.86)</td><td rowspan="2" align="center" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0.76 (0.65&#8211;0.87)</td><td align="center" rowspan="1" colspan="1">0.79 (0.73&#8211;0.86)</td></tr><tr><td rowspan="3" align="left" colspan="1">Classification model</td><td align="left" rowspan="1" colspan="1">Classification model LR</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">0.70 (0.64&#8211;0.76)</td><td rowspan="3" align="center" colspan="1">0.25</td><td align="center" rowspan="1" colspan="1">0.83 (0.78&#8211;0.89)</td><td rowspan="3" align="center" colspan="1">0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">Classification model SVM</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">0.71 (0.60&#8211;0.82)</td><td align="center" rowspan="1" colspan="1">0.85 (0.80&#8211;0.90)</td></tr><tr><td align="left" rowspan="1" colspan="1">Other classification models</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">0.82 (0.70&#8211;0.94)</td><td align="center" rowspan="1" colspan="1">0.77 (0.71&#8211;0.83)</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>Cochran&#8217;s Q statistics for heterogeneity</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec><title>Sensitivity analyses</title><p>In the sensitivity analyses shown in Table <xref rid="T4" ref-type="table">4</xref>, no significant changes in overall heterogeneity were observed when each study was removed individually. Therefore, the results are consistent with those of the main analyses.<table-wrap position="float" id="T4" orientation="portrait"><label>Table 4</label><caption><p>The results of sensitivity analysis of the included studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="left" rowspan="1" colspan="1">Sensitivity</th><th align="left" rowspan="1" colspan="1">Specificity</th><th align="left" rowspan="1" colspan="1">PLR</th><th align="left" rowspan="1" colspan="1">NLR</th><th align="left" rowspan="1" colspan="1">DOR</th><th align="left" rowspan="1" colspan="1">AUC</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Arefan</td><td align="center" rowspan="1" colspan="1">0.749 (0.684, 0.805)</td><td align="center" rowspan="1" colspan="1">0.800 (0.764, 0.832)</td><td align="center" rowspan="1" colspan="1">3.744 (3.190, 4.396)</td><td align="center" rowspan="1" colspan="1">0.240 (0.066, 0.878)</td><td align="center" rowspan="1" colspan="1">14.064(9.293, 21.283)</td><td align="center" rowspan="1" colspan="1">0.83 (0.79,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Huifang chen</td><td align="center" rowspan="1" colspan="1">0.752 (0 .690,0 .805)</td><td align="center" rowspan="1" colspan="1">0.807 (0.774, 0.837)</td><td align="center" rowspan="1" colspan="1">3.891 (3.441, 4.399)</td><td align="center" rowspan="1" colspan="1">0.229 (0.063, 0.835)</td><td align="center" rowspan="1" colspan="1">15.281 (10.807, 21.607)</td><td align="center" rowspan="1" colspan="1">0.84 (0.81,0.87)</td></tr><tr><td align="left" rowspan="1" colspan="1">Danxiang chen</td><td align="center" rowspan="1" colspan="1">0 .749(0 .684,0. 805)</td><td align="center" rowspan="1" colspan="1">0.795 (0.761, 0.026)</td><td align="center" rowspan="1" colspan="1">3.708 (3.169, 4.338)</td><td align="center" rowspan="1" colspan="1">0.240(0.065, 0.881)</td><td align="center" rowspan="1" colspan="1">14.073(9.240, 21.433)</td><td align="center" rowspan="1" colspan="1">0.82 (0.79,0.85)</td></tr><tr><td align="left" rowspan="1" colspan="1">Yanhong chen</td><td align="center" rowspan="1" colspan="1">0 .749 (0. 682,0. 805)</td><td align="center" rowspan="1" colspan="1">0.806(0.767, 0.840)</td><td align="center" rowspan="1" colspan="1">3.837 (3.234, 4.552)</td><td align="center" rowspan="1" colspan="1">0.239(0.064, 0.889)</td><td align="center" rowspan="1" colspan="1">14.980(9.847, 22.788)</td><td align="center" rowspan="1" colspan="1">0.84 (0.80,0.87)</td></tr><tr><td align="left" rowspan="1" colspan="1">Jia Liu</td><td align="center" rowspan="1" colspan="1">0.744 (0. 679,0. 800)</td><td align="center" rowspan="1" colspan="1">0.804 (0.767, 0.836)</td><td align="center" rowspan="1" colspan="1">3.780 (3.207, 4.456)</td><td align="center" rowspan="1" colspan="1">0.242(0.066, 0.884)</td><td align="center" rowspan="1" colspan="1">14.251(9.469, 21.449)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lu Han</td><td align="center" rowspan="1" colspan="1">0.735 (0. 669,0. 792)</td><td align="center" rowspan="1" colspan="1">0.805 (0.766,0.839)</td><td align="center" rowspan="1" colspan="1">3.744 (3.150,4.449)</td><td align="center" rowspan="1" colspan="1">0.249(0.065, 0.954)</td><td align="center" rowspan="1" colspan="1">13.771(9.034, 20.994)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mingming Ma</td><td align="center" rowspan="1" colspan="1">0.735(0. 669,0. 791)</td><td align="center" rowspan="1" colspan="1">0.800 (0.763,0.832)</td><td align="center" rowspan="1" colspan="1">3.677 (3.142, 4.304)</td><td align="center" rowspan="1" colspan="1">0.252(0.067, 0.947)</td><td align="center" rowspan="1" colspan="1">13.281(8.889, 19.845)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Xiaomign Qiu</td><td align="center" rowspan="1" colspan="1">0 .744(0. 678,0. 800)</td><td align="center" rowspan="1" colspan="1">0.802 (0.766,0.833)</td><td align="center" rowspan="1" colspan="1">3.756 (3.210, 4.394)</td><td align="center" rowspan="1" colspan="1">0.245(0.067, 0.890)</td><td align="center" rowspan="1" colspan="1">13.813(9.256, 20.613)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Yuan Cheng</td><td align="center" rowspan="1" colspan="1">0. 736(0. 670,0. 793)</td><td align="center" rowspan="1" colspan="1">0.810 (0.775,0.841)</td><td align="center" rowspan="1" colspan="1">3.890 (3.314, 4.567)</td><td align="center" rowspan="1" colspan="1">0.247 (0.065, 0. 938)</td><td align="center" rowspan="1" colspan="1">14.422(9.455, 21.999)</td><td align="center" rowspan="1" colspan="1">0.84 (0.80,0.87)</td></tr><tr><td align="left" rowspan="1" colspan="1">Chunling Liu</td><td align="center" rowspan="1" colspan="1">0.742(0. 676,0. 798)</td><td align="center" rowspan="1" colspan="1">0.801(0.764,0.834)</td><td align="center" rowspan="1" colspan="1">3.732 (3.171, 4.394)</td><td align="center" rowspan="1" colspan="1">0.246 (0.066, 0.907)</td><td align="center" rowspan="1" colspan="1">13.933(9.201, 21.097)</td><td align="center" rowspan="1" colspan="1">0.83 (0.79,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mingzhen Chen</td><td align="center" rowspan="1" colspan="1">0. 747(0. 682,0. 803)</td><td align="center" rowspan="1" colspan="1">0.808(0.769,0.841)</td><td align="center" rowspan="1" colspan="1">3.858 (3.257, 4.570)</td><td align="center" rowspan="1" colspan="1">0.239 (0.064, 0.891)</td><td align="center" rowspan="1" colspan="1">14.942(9.848, 22.669)</td><td align="center" rowspan="1" colspan="1">0.84 (0.81,0.87)</td></tr><tr><td align="left" rowspan="1" colspan="1">Meijie Liu</td><td align="center" rowspan="1" colspan="1">0.744(0. 677,0. 800)</td><td align="center" rowspan="1" colspan="1">0.804(0.767,0.837)</td><td align="center" rowspan="1" colspan="1">3.782 (3.201, 4.469)</td><td align="center" rowspan="1" colspan="1">0.243(0.066, 0.893)</td><td align="center" rowspan="1" colspan="1">14.352(9.458, 21.778)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Yadi Zhu</td><td align="center" rowspan="1" colspan="1">0 .747(0. 681,0. 803)</td><td align="center" rowspan="1" colspan="1">0.800(0.764,0.832)</td><td align="center" rowspan="1" colspan="1">3.738 (3.182, 4.392)</td><td align="center" rowspan="1" colspan="1">0.241 (0.066, 0.885)</td><td align="center" rowspan="1" colspan="1">14.052(9.266, 21.310)</td><td align="center" rowspan="1" colspan="1">0.83 (0.79,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Deling Song</td><td align="center" rowspan="1" colspan="1">0. 743(0. 674,0. 801)</td><td align="center" rowspan="1" colspan="1">0.805(0.766,0.839)</td><td align="center" rowspan="1" colspan="1">3.778 (3.175, 4.495)</td><td align="center" rowspan="1" colspan="1">0.244(0.065, 0.919)</td><td align="center" rowspan="1" colspan="1">14.395(9.337, 22.193)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hongna Tan</td><td align="center" rowspan="1" colspan="1">0.750(0. 685,0. 805)</td><td align="center" rowspan="1" colspan="1">0.799(0.763,0.831)</td><td align="center" rowspan="1" colspan="1">3.744 (3.180, 4.408)</td><td align="center" rowspan="1" colspan="1">0.239 (0.065, 0.876)</td><td align="center" rowspan="1" colspan="1">14.319(9.413, 21.782)</td><td align="center" rowspan="1" colspan="1">0.83 (0.79,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Jian Wang</td><td align="center" rowspan="1" colspan="1">0.731(0. 679,0. 777)</td><td align="center" rowspan="1" colspan="1">0.812(0.776, 0.843)</td><td align="center" rowspan="1" colspan="1">3.783 (3.128, 4.576)</td><td align="center" rowspan="1" colspan="1">0.309(0.252, 0.379)</td><td align="center" rowspan="1" colspan="1">12.781(9.310, 17.545)</td><td align="center" rowspan="1" colspan="1">0.85 (0.82,0.88)</td></tr><tr><td align="left" rowspan="1" colspan="1">Yusi Chen</td><td align="center" rowspan="1" colspan="1">0.742(0. 676,0. 799)</td><td align="center" rowspan="1" colspan="1">0.801(0.764, 0.833)</td><td align="center" rowspan="1" colspan="1">3.732(3.175, 4.387)</td><td align="center" rowspan="1" colspan="1">0.245(0.066, 0.902)</td><td align="center" rowspan="1" colspan="1">13.908(9.188, 21.053)</td><td align="center" rowspan="1" colspan="1">0.83 (0.79,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ying Liu</td><td align="center" rowspan="1" colspan="1">0 .751(0. 687,0. 805)</td><td align="center" rowspan="1" colspan="1">0.804(0.766, 0.837)</td><td align="center" rowspan="1" colspan="1">3.808(3.221, 4.502)</td><td align="center" rowspan="1" colspan="1">0.237 (0.064, 0.870)</td><td align="center" rowspan="1" colspan="1">14.914(9.871, 22.533)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dawey Wang</td><td align="center" rowspan="1" colspan="1">0. 740(0. 674,0. 797)</td><td align="center" rowspan="1" colspan="1">0.807(0.770,0.839)</td><td align="center" rowspan="1" colspan="1">3.810(3.222, 4.506)</td><td align="center" rowspan="1" colspan="1">0.246 (0.066, 0.912)</td><td align="center" rowspan="1" colspan="1">14.313(9.423, 21.741)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr><tr><td align="left" rowspan="1" colspan="1">Domiziana Santucci</td><td align="center" rowspan="1" colspan="1">0.732(0. 667,0. 788)</td><td align="center" rowspan="1" colspan="1">0.807(0.770, 0.840)</td><td align="center" rowspan="1" colspan="1">3.812(3.219, 4.512)</td><td align="center" rowspan="1" colspan="1">0.250 (0.067, 0.934)</td><td align="center" rowspan="1" colspan="1">14.041(9.200, 21.429)</td><td align="center" rowspan="1" colspan="1">0.83 (0.80,0.86)</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>AUC: area under the curve, DOR: diagnostic odds ratio, NLR: negative likelihood ratio, PLR: positive likelihood ratio.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec><title>Publication bias</title><p>Deek&#8217;s funnel plot revealed a <italic toggle="yes">P</italic> value of 0.06, as assessed through Egger&#8217;s test, suggesting the absence of publication bias among studies (Fig. <xref rid="F6" ref-type="fig">6</xref>).<fig position="float" id="F6" orientation="portrait"><label>Figure 6.</label><caption><p>Deek&#8217;s funnel plot representing publication bias.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6412-g006.jpg"/></fig>
</p></sec><sec><title>Clinical utility</title><p>In Fagan&#8217;s nomogram, using radiomics models increased the likelihood of having positive LNM when the initial probability was already positive, raising it from 37% to 73.2%. On the other hand, when the initial probability was negative, the use of the radiomics model lowered the likelihood of the positive LNM to just 8% with a negative likelihood ratio of 0.36 (Fig. <xref rid="F7" ref-type="fig">7</xref>).<fig position="float" id="F7" orientation="portrait"><label>Figure 7.</label><caption><p>Fagan&#8217;s nomogram showing the relationship between pre-test probability, likelihood ratio, and post-test probability for the diagnostic performance of radiomics.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6412-g007.jpg"/></fig>
</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>This systematic review and meta-analysis aimed to evaluate the diagnostic performance of radiomics models for predicting LNM in patients with breast cancer. In the analysis, 20 studies with a patient number of 5072 individuals were included. The radiomics models showed promising results with an AUC of 0.83 indicating a strong capability of these models to distinguish patients with and without LNM, showing the potential role of radiomics in clinical settings. The models&#8217; pooled sensitivity of 0.78 and specificity of 0.81 further highlight the effectiveness of these models, though the significant heterogeneity observed in sensitivity (I<sup>2</sup>&#160;=&#160;86.99%) suggests variability across studies. This heterogeneity may be attributed to methodological differences, including study design (prospective vs. retrospective), sample size, and the use of MRI scanners with varying protocols and field strengths (1.5 vs. 3 Tesla) (Table <xref rid="T1" ref-type="table">1</xref>). Furthermore, the radiomics workflows differed notably across studies, with variations in segmentation strategy, feature extraction tools, and classification algorithms, as presented in Table <xref rid="T1" ref-type="table">1</xref>. Among these factors, the field strength was the only variable that indicated a statistically significant difference in sensitivity range (Table <xref rid="T3" ref-type="table">3</xref>). Although other factors individually may have had a minimal impact, their combined influence likely exacerbated the observed variability.</p><p>The results of sensitivity analyses for all 20 studies showed that removing any single study had no significant impact on the pooled sensitivity and specificity, indicating the robustness of our results. Furthermore, the absence of publication bias, as indicated by Deek&#8217;s funnel plot (<italic toggle="yes">P</italic> =&#160;0.06), enhances the reliability of our findings and suggests that our conclusions regarding the predictive capabilities of radiomics in LNM are sound. Regarding the clinical utility of radiomics, the models elevated the likelihood of positive LNM from an initial probability of 37% to 73.2%. Conversely, when the pre-test probability of LNM was negative, radiomics models significantly reduced the likelihood of a positive LNM to 8%, with a negative likelihood ratio of 0.36.</p><p>19/20 studies included in this analysis were retrospective, with only one prospective study noted. Despite the probable complications associated with retrospective designs, such as selection bias and incomplete data, our findings did not demonstrate significant differences in the sensitivity (0.74 vs. 0.73) and specificity (0.82 vs. 0.81) in retrospective and prospective studies (Table <xref rid="T3" ref-type="table">3</xref>). This suggest that even models developed with retrospective data can achieve substantial predictive accuracy. However, future studies should aim to incorporate more prospective designs to strengthen the evidence base and enhance generalizability.</p><p>Studies that combined radiomics features with clinical parameters reported a higher pooled specificity (0.83 vs. 0.79) and a lower pooled sensitivity (0.74 vs. 0.76) compared to those relying solely on radiomics (Table <xref rid="T3" ref-type="table">3</xref>). In terms of specificity, studies integrating radiomics with clinical and pathological parameters achieved specificities of 0.80, 0.86, 0.89, and 0.88<sup>[<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>]</sup>. However, a study that utilized a combination of radiomics and molecular biomarkers reported a specificity of 1<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup>. Regarding sensitivity, clinicopathological models yielded values of 0.65, 0.77, 0.60, and 0.76<sup>[<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R30" ref-type="bibr">30</xref>]</sup>, while the study that integrated molecular biomarkers achieved a sensitivity of 0.72<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup>. Other studies with combined models explored various combinations of radiomics with different clinical parameters. For instance, Han <italic toggle="yes">et al</italic> built a nomogram by integrating radiomics with clinical factors such as LN status and LN palpability, resulting in a sensitivity of 0.85 and specificity of 0.80<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup>. Similarly, Zhu <italic toggle="yes">et al</italic> created a nomogram by combining radiomics with tumor size and BI-RADS classification, achieving a sensitivity: 0.68 and specificity: 0.90<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup>. In another study by Song <italic toggle="yes">et al</italic>, the radiomics were combined with histological grade, multifocality, and MRI-reported LN status, resulting in a sensitivity: 0.75 and specificity of 0.80<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup>. It is noteworthy that the potential of the improved specificity accompanying clinical integration reflects a more accurate identification of true positives, which is especially critical in cancer care for reducing false positives. However, the resulting decrease in sensitivity raises concerns about the possibility of missing true positive cases, particularly those cases that are less prominent or have ambiguous imaging results. Therefore, a careful balance must be struck between maximizing sensitivity and specificity, depending on the clinical context and the specific patient population being assessed. These findings show the potential of integrating models of radiomics with different clinical factors as well as pathological characteristics and even molecular biomarkers. Future studies with a main focus of comparing different combined models are needed to determine which clinical factors, when integrated with radiomics, yield the most effective predictive models.</p><p>The subgroup analysis revealed that MRI performance for detecting LNM vary across different magnetic field strengths. Specifically, 1.5 Tesla MRI showed significantly higher sensitivity (0.86) compared to 3 Tesla MRI (0.72) which contradicts with conventional expectations. Conversely, 3 Tesla MRI exhibited slightly higher specificity (0.84) compared to 1.5 Tesla MRI (0.79). To the best of our knowledge, the current evidence on whether 3 Tesla MRI offers greater diagnostic accuracy than 1.5 Tesla for breast cancer remains inadequate. As it has been noted, the sensitivity and specificity of MRI at different field strengths are affected by the anatomical location of the tumor and technical considerations<sup>[<xref rid="R39" ref-type="bibr">39</xref>]</sup>, including imaging sequences, coil configurations, and the application of contrast agents<sup>[<xref rid="R40" ref-type="bibr">40</xref>]</sup>. Although some studies indicated a higher rate of sensitivity and specificity for 3 Tesla compared to 1.5 Tesla MRI<sup>[<xref rid="R41" ref-type="bibr">41</xref>]</sup>, there are also instances of divergent data. In a study conducted by Djilas, significantly greater contrast enhancement rates were noted at 1.5 Tesla compared to 3.0&#160;Tesla<sup>[<xref rid="R42" ref-type="bibr">42</xref>]</sup>. Dietzel <italic toggle="yes">et al</italic> examined images from 1961 breasts of 982 patients over a 12-month period, with 1746 breasts (89%) scanned using 1.5 Tesla system and 215 (11%) using a 3 Tesla system. The results showed that the 1.5 Tesla and 3 Tesla MRI scanners had diagnostic accuracies of 92% and 91.2%, respectively, with no statistically significant difference between the two (<italic toggle="yes">P</italic> =&#160;0.68)<sup>[<xref rid="R43" ref-type="bibr">43</xref>]</sup>. There are also studies in other tumors like prostate cancer where 1.5 Tesla MRI was better than 3 Tesla in tumor delineation<sup>[<xref rid="R44" ref-type="bibr">44</xref>]</sup>.</p><p>In this regard, Ohba <italic toggle="yes">et al</italic> demonstrated that 3.0 Tesla MRI and 1.5 Tesla MRI showed comparable effectiveness in detecting 58 malignant pulmonary nodules in a cohort of 76 patients<sup>[<xref rid="R44" ref-type="bibr">44</xref>]</sup>. Nevertheless, 3 Tesla MRI has some disadvantages including increased B1 field inhomogeneity<sup>[<xref rid="R45" ref-type="bibr">45</xref>]</sup> and it is a heavier device that needs a larger room and potentially additional structural support. While some studies have indicated that 3.0 Tesla MRI performs better in clinical test parameters, such as lesion count and lesion positioning, it remains uncertain whether these advantages result in significant benefits for patients<sup>[<xref rid="R42" ref-type="bibr">42</xref>,<xref rid="R44" ref-type="bibr">44</xref>]</sup>. Therefore, further investigations comparing the effect of MRI magnetic field strength on patient management outcomes would be beneficial. According to the results presented in Table <xref rid="T1" ref-type="table">1</xref>, the sensitivity and specificity of 1.5 Tesla and 3 Tesla MRI were evaluated across patients in different centers, and different MRI scanner models with varying protocols. It is noteworthy that the controversial results may be provided due to study design imbalances, difference in protocols, or sample size limitations. Therefore, to gain a clearer understanding of the role of each magnetic field strength in detecting LNM in breast cancer patients, prospective studies with larger sample sizes utilizing consistent imaging and standardized radiomics algorithms with balanced study designs are needed.</p><p>The analysis also revealed comparable diagnostic performance between DCE-MRI and non-DCE-MRI for lymph node metastasis detection, with no significant differences in sensitivity and specificity. This finding suggest that the addition of dynamic contrast sequences may not provide substantial added value in radiomics analysis, which could have implications for imaging protocol selection and efficiency.</p><p>In radiomics studies, two main processes are feature extraction and feature selection. Feature extraction involves mathematical analyses and image processing techniques to identify the most prevalent patterns within an image. Feature selection helps to avoid overfitting by reducing the number of extracted features to the smallest subsets that accurately represents the data<sup>[<xref rid="R46" ref-type="bibr">46</xref>]</sup>. Pyradiomcs was the most prevalent platform that was utilized in studies (8/20). Pyradiomics, an open-source Python package, is highly recommended as it offers greater replicability and standardization compared to house-built software<sup>[<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R47" ref-type="bibr">47</xref>-<xref rid="R50" ref-type="bibr">50</xref>]</sup>.</p><p>Regarding different frameworks for feature extraction, our analysis revealed that Radcloud demonstrates strong performance in accurately identifying non metastatic lymph nodes, achieving the highest specificity of 0.87 while maintain a sensitivity of 0.75. The open-source platform Pyradiomics showed comparable LNM selection capabilities with a sensitivity of 0.75.</p><p>For feature selection, the majority of included studies (14/20) utilized the LASSO regression method. LASSO automatically selects the most important features while removes less relevant ones by adding a special mathematical term that reduces unnecessary variables to zero, making the final model both simpler and more reliable for clinical interpretation<sup>[<xref rid="R51" ref-type="bibr">51</xref>]</sup> (Supplementary Table S1, Supplemental Digital Content, available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/js9/e401" ext-link-type="uri">http://links.lww.com/js9/e401</ext-link>).</p><p>In this systematic review, we assessed the quality of the included studies using both the QUADAS and RQS tools. QUADAS results showed acceptable scores. However, 60% of the studies lacked sufficient information in the timing and flow domain. Clinically, the time between lymph node biopsy (the reference standard) and MRI imaging (the index test) is typically short enough that it may not substantially affect the conversion of a negative lymph node to a positive result. However, accurately reporting this timing in future studies would be beneficial. In RQS assessment, 90% of the studies were retrospective. These studies often rely on specific clinical data and may not be represented of broader patient population. Issues with data quality and inability to accurately assess the timing between MRI and biopsy can affect the interpretations and confounding factors are less manageable in retrospective studies than in prospective studies. Notably, some of our included studies utilized external validation to enhance the generalizability of their results.</p><p>Although the number of research studies utilizing radiomics is increasing, there is a lack of standardization in the field of radiomics due to low rates of comparability and repeatability of radiomics models<sup>[<xref rid="R52" ref-type="bibr">52</xref>]</sup>. Therefore, while the results of our analysis confirm the promising performance of radiomics in detecting LNM in breast cancer, we should take into account the variability in the methodology and model development across current studies in this field. One big challenge is that imaging methods can vary across machines, technical settings and reconstruction methods, which can make results inconsistent<sup>[<xref rid="R53" ref-type="bibr">53</xref>]</sup>. Recently, techniques like ComBat have been presented to help manage these differences in data from multiple centers<sup>[<xref rid="R54" ref-type="bibr">54</xref>]</sup>. However, radiomics models that use standardized imaging techniques and high-quality data can reduce problems caused by different workflows in multicenter collaborations where data heterogeneity exists<sup>[<xref rid="R55" ref-type="bibr">55</xref>]</sup>. This process refers to standardize techniques<sup>[<xref rid="R56" ref-type="bibr">56</xref>]</sup>, especially in segmenting index lesions during the training phase<sup>[<xref rid="R57" ref-type="bibr">57</xref>,<xref rid="R58" ref-type="bibr">58</xref>]</sup>. To improve the quality of radiomics datasets for training, testing, and validation, it is important to update these datasets to include statistical validation metrics, parameters for clinical integration, and methods for assessing algorithm performance in both research and clinical settings<sup>[<xref rid="R55" ref-type="bibr">55</xref>,<xref rid="R59" ref-type="bibr">59</xref>]</sup>.</p><p>In 2025, Schwarzhans <italic toggle="yes">et al</italic> explored the role of standardizing normalization methods in analyzing the heterogeneous datasets of breast MRI images. Their findings demonstrated that there is no universal normalization method that fits all datasets; rather, customized approaches should be investigated to determine the optimal combination of normalization techniques for each dataset. Their results also showed that normalization in predictive models are more effective in smaller training datasets rather than larger ones<sup>[<xref rid="R60" ref-type="bibr">60</xref>]</sup>. The absence of large datasets is a major barrier to the widespread use of AI systems in healthcare, as the level of data curation needed depends on both the number of cases and the radiomics methods used. A larger sample size in radiomics studies is important for improving predictive models; bigger datasets can lead to better accuracy and allow for the use of radiomics that produce stronger results. Unfortunately, many of the studies conducted so far have not used large enough sample sizes, showing that more research is needed to validate these models<sup>[<xref rid="R61" ref-type="bibr">61</xref>]</sup>. Future studies could also investigate repeated train-test splits or different cross-validation methods, considering normalization as a model hyperparameter. This approach would help minimize the risk of overestimating performance improvements and result in a more trustworthy selection of preprocessing techniques. Given that MRI results exhibit a wide range of variability in image reconstruction algorithms magnetic field strength and scanner manufacturer and pulse sequence<sup>[<xref rid="R62" ref-type="bibr">62</xref>,<xref rid="R63" ref-type="bibr">63</xref>]</sup>, a validated technical profile for MRI radiomics is still lacking<sup>[<xref rid="R64" ref-type="bibr">64</xref>]</sup>.</p><p>This systematic review and meta-analysis indicate some limitations. Most of the included studies were retrospective and one of them was prospective which introduces potential biases and reduces generalizability as well as underscoring the significance of conducting future prospective research studies to evaluate the validity of prospective designs compared to retrospective ones. Furthermore, most of the studies were conducted in China raising concerns about the applicability of findings to diverse populations and healthcare systems worldwide. Significant heterogeneity in sensitivity across studies further complicates the interpretation of results, suggesting variability in model performance across different settings and populations. Future radiomics research should prioritize developing standardized MRI acquisition protocols in the radiomic workflow. In this regard, creating universal calibration phantoms, implement robust normalization and multi-centric validation strategies as well as exploring advanced techniques like ComBat in future studies seems necessary.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>This study demonstrates the potential of radiomics as a non-invasive alternative for predicting LNM in breast cancer. To facilitate the integration of radiomics into clinical practice, it seems that further investigations on prospective designs, external validation, and adherence to standardized workflows are needed.</p></sec></body><back><ack><title>Acknowledgements</title><p>We would like to express our deep appreciation to Dr. Khoosheh Rassam for her invaluable guidance before and during the course of this research. As a radiologist with years of experience in breast imaging, Dr. Rassam has dedicated her career to caring for patients with breast cancer in Guilan Province. We hope that this research will contribute to advancing the breast cancer community toward safer and more accurate management practices.</p></ack><fn-group><fn fn-type="other"><p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p></fn><fn fn-type="other"><p>Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.lww.com/international-journal-of-surgery" ext-link-type="uri">www.lww.com/international-journal-of-surgery</ext-link>.</p></fn><fn fn-type="equal"><p>Published online 20 June 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>As our study was a systematic review-meta analysis, we did not obtain an ethical approval.</p></sec><sec><title>Consent</title><p>As our study was a systematic review-meta analysis, we did not obtain a consent form.</p></sec><sec><title>Sources of funding</title><p>The authors received no funding for this research.</p></sec><sec><title>Author contributions</title><p>We acknowledge the co-first authorship of M.M. and S.S. for their equal contributions to this work. Both M.M. and S.S. conducted the literature search and authored the manuscript, while also taking responsibility for the study design, data collection, and processing. S.F. and A.F. handled the data extraction. A.H. and K.R. provided supervision throughout the manuscript&#8217;s implementation. A.T., M.M., and N.S. were involved in data analysis and interpretation, with contributions to concept development from S.S., A.H., and M.M. M.M. and A.T. oversaw the organization and writing of the manuscript, and all authors participated in drafting the final version.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>The authors declare no conflict of interest.</p></sec><sec><title>Guarantor</title><p>Afagh Hasanzadehrad.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>Name of the registry: PROSPERO. Registration ID: CRD42024536173. Hyperlink to your specific registration: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=536173" ext-link-type="uri">https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=536173</ext-link>.</p></sec><sec><title>Provenance and peer review</title><p>Not commissioned, externally peer-reviewed.</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Distant metastasis prediction via a multi-feature fusion model in breast cancer</article-title>. <source>Aging</source><year>2020</year>;<volume>12</volume>:<fpage>18151</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="pmid">32989175</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/aging.103630</pub-id><pub-id pub-id-type="pmcid">PMC7585122</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bao</surname><given-names>L</given-names></name><name name-style="western"><surname>Shu</surname><given-names>P</given-names></name></person-group>. <article-title>The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019</article-title>. <source>Front Oncol</source><year>2024</year>;<volume>14</volume>:<fpage>1364397</fpage>.<pub-id pub-id-type="pmid">38966067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2024.1364397</pub-id><pub-id pub-id-type="pmcid">PMC11222408</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Radiomics analysis of dynamic contrast-enhanced magnetic resonance imaging for the prediction of sentinel lymph node metastasis in breast cancer</article-title>. <source>Front Oncol</source><year>2019</year>:<fpage>9</fpage>.<pub-id pub-id-type="pmid">31632912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2019.00980</pub-id><pub-id pub-id-type="pmcid">PMC6778833</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kootstra</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Dijkstra</surname><given-names>PU</given-names></name><name name-style="western"><surname>Rietman</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection</article-title>. <source>Breast Cancer Res Treat</source><year>2013</year>;<volume>139</volume>:<fpage>125</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="pmid">23588950</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10549-013-2509-y</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kootstra</surname><given-names>J</given-names></name><name name-style="western"><surname>Hoekstra-Weebers</surname><given-names>JE</given-names></name><name name-style="western"><surname>Rietman</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study</article-title>. <source>Ann Surg Oncol</source><year>2008</year>;<volume>15</volume>:<fpage>2533</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="pmid">18597146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1245/s10434-008-9996-9</pub-id><pub-id pub-id-type="pmcid">PMC2518082</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Ren</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Predicting of axillary lymph node metastasis in invasive breast cancer using multiparametric MRI dataset based on CNN model</article-title>. <source>Front Oncol</source><year>2022</year>:<fpage>12</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.1069733</pub-id><pub-id pub-id-type="pmcid">PMC9763602</pub-id><pub-id pub-id-type="pmid">36561533</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Development of the prediction model based on clinical-imaging omics: molecular typing and sentinel lymph node metastasis of breast cancer</article-title>. <source>Ann Translat Med</source><year>2022</year>;<volume>10</volume>:<fpage>749</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/atm-22-2844</pub-id><pub-id pub-id-type="pmcid">PMC9358505</pub-id><pub-id pub-id-type="pmid">35957717</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faraji</surname><given-names>N</given-names></name><name name-style="western"><surname>Aali</surname><given-names>S</given-names></name><name name-style="western"><surname>Motiei</surname><given-names>M</given-names></name><name name-style="western"><surname>Sadat Mansouri</surname><given-names>S</given-names></name></person-group>. <article-title>Letter to the Editor: ChatGPT&#8217;s contribution to cancer study</article-title>. <source>J Cancer Res Clin Oncol</source><year>2023</year>;<volume>149</volume>:<fpage>13495</fpage>&#8211;<lpage>500</lpage>.<pub-id pub-id-type="pmid">37462773</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00432-023-05183-2</pub-id><pub-id pub-id-type="pmcid">PMC11797205</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambin</surname><given-names>P</given-names></name><name name-style="western"><surname>Rios-Velazquez</surname><given-names>E</given-names></name><name name-style="western"><surname>Leijenaar</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Radiomics: extracting more information from medical images using advanced feature analysis</article-title>. <source>Eur J Cancer</source><year>2012</year>;<volume>48</volume>:<fpage>441</fpage>&#8211;<lpage>46</lpage>.<pub-id pub-id-type="pmid">22257792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejca.2011.11.036</pub-id><pub-id pub-id-type="pmcid">PMC4533986</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbaspour</surname><given-names>E</given-names></name><name name-style="western"><surname>Karimzadhagh</surname><given-names>S</given-names></name><name name-style="western"><surname>Monsef</surname><given-names>A</given-names></name><name name-style="western"><surname>Joukar</surname><given-names>F</given-names></name><name name-style="western"><surname>Mansour-Ghanaei</surname><given-names>F</given-names></name><name name-style="western"><surname>Hassanipour</surname><given-names>S</given-names></name></person-group>. <article-title>Application of radiomics for preoperative prediction of lymph node metastasis in colorectal cancer: a systematic review and meta-analysis</article-title>. <source>Int J Surg</source><year>2024</year>;<volume>110</volume>:<fpage>3795</fpage>&#8211;<lpage>813</lpage>.<pub-id pub-id-type="pmid">38935817</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JS9.0000000000001239</pub-id><pub-id pub-id-type="pmcid">PMC11175807</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mortellaro</surname><given-names>VE</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>J</given-names></name><name name-style="western"><surname>Singer</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Magnetic resonance imaging for axillary staging in patients with breast cancer</article-title>. <source>J Magn Reson Imaging</source><year>2009</year>;<volume>30</volume>:<fpage>309</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="pmid">19466713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmri.21802</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer</article-title>. <source>Quant Imaging Med Surg</source><year>2019</year>;<volume>10</volume>:<fpage>197</fpage>&#8211;<lpage>210</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/qims.2019.11.16</pub-id><pub-id pub-id-type="pmcid">PMC6960417</pub-id><pub-id pub-id-type="pmid">31956542</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sohrabi</surname><given-names>C</given-names></name><name name-style="western"><surname>Franchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>PRISMA 2020 statement: what&#8217;s new and the importance of reporting guidelines</article-title>. <source>Int J Surg</source><year>2021</year>;<volume>88</volume>:<fpage>105918</fpage>.<pub-id pub-id-type="pmid">33789825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijsu.2021.105918</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shea</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>BC</given-names></name><name name-style="western"><surname>Wells</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both</article-title>. <source>BMJ (Clinical Research Ed)</source><year>2017</year>;<volume>358</volume>:<fpage>j4008</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.j4008</pub-id><pub-id pub-id-type="pmcid">PMC5833365</pub-id><pub-id pub-id-type="pmid">28935701</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambin</surname><given-names>P</given-names></name><name name-style="western"><surname>Leijenaar</surname><given-names>RTH</given-names></name><name name-style="western"><surname>Deist</surname><given-names>TM</given-names></name><etal/></person-group>. <article-title>Radiomics: the bridge between medical imaging and personalized medicine</article-title>. <source>Nat Rev Clin Oncol</source><year>2017</year>;<volume>14</volume>:<fpage>749</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="pmid">28975929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrclinonc.2017.141</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>BC</given-names></name><name name-style="western"><surname>Dahabreh</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Trikalinos</surname><given-names>TA</given-names></name><name name-style="western"><surname>Lau</surname><given-names>J</given-names></name><name name-style="western"><surname>Trow</surname><given-names>P</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>CH</given-names></name></person-group>. <article-title>Closing the gap between methodologists and end-users: r as a computational back-end</article-title>. <source>J Stat Software</source><year>2012</year>;<volume>49</volume>:<fpage>1</fpage>&#8211;<lpage>15</lpage>.</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viechtbauer</surname><given-names>W</given-names></name></person-group>. <article-title>Conducting meta-analyses in r with the metafor package</article-title>. <source>J Stat Software</source><year>2010</year>;<volume>36</volume>:<fpage>1</fpage>&#8211;<lpage>48</lpage>.</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwier</surname><given-names>M</given-names></name><name name-style="western"><surname>van Griethuysen</surname><given-names>J</given-names></name><name name-style="western"><surname>Vangel</surname><given-names>MG</given-names></name><etal/></person-group>. <article-title>Repeatability of multiparametric prostate MRI radiomics features</article-title>. <source>Sci Rep</source><year>2019</year>;<volume>9</volume>:<fpage>9441</fpage>.<pub-id pub-id-type="pmid">31263116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-45766-z</pub-id><pub-id pub-id-type="pmcid">PMC6602944</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rutter</surname><given-names>CM</given-names></name><name name-style="western"><surname>Gatsonis</surname><given-names>CA</given-names></name></person-group>. <article-title>A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations</article-title>. <source>Stat Med</source><year>2001</year>;<volume>20</volume>:<fpage>2865</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="pmid">11568945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/sim.942</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arefan</surname><given-names>D</given-names></name><name name-style="western"><surname>Chai</surname><given-names>R</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Zuley</surname><given-names>ML</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S</given-names></name></person-group>. <article-title>Machine learning prediction of axillary lymph node metastasis in breast cancer: 2D versus 3D radiomic features</article-title>. <source>Med Phys</source><year>2020</year>;<volume>47</volume>:<fpage>6334</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="pmid">33058224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mp.14538</pub-id><pub-id pub-id-type="pmcid">PMC8581816</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santucci</surname><given-names>D</given-names></name><name name-style="western"><surname>Faiella</surname><given-names>E</given-names></name><name name-style="western"><surname>Cordelli</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>3T MRI-radiomic approach to predict for lymph node status in breast cancer patients</article-title>. <source>Cancers</source><year>2021</year>;<volume>13</volume>:<fpage>2228</fpage>.<pub-id pub-id-type="pmid">34066451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers13092228</pub-id><pub-id pub-id-type="pmcid">PMC8124168</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Shen</surname><given-names>H</given-names></name></person-group>. <article-title>Value of the application of CE-MRI radiomics and machine learning in preoperative prediction of sentinel lymph node metastasis in breast cancer</article-title>. <source>Front Oncol</source><year>2021</year>;<volume>11</volume>:<fpage>757111</fpage>.<pub-id pub-id-type="pmid">34868967</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2021.757111</pub-id><pub-id pub-id-type="pmcid">PMC8640128</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>H</given-names></name><name name-style="western"><surname>Gan</surname><given-names>F</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Preoperative prediction of axillary lymph node metastasis in breast carcinoma using radiomics features based on the fat-suppressed T2 sequence</article-title>. <source>Acad Radiol</source><year>2020</year>;<volume>27</volume>:<fpage>1217</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">31879160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.acra.2019.11.004</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>D</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer</article-title>. <source>Cancer Imaging</source><year>2022</year>;<volume>22</volume>:<fpage>17</fpage>.<pub-id pub-id-type="pmid">35379339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40644-022-00450-w</pub-id><pub-id pub-id-type="pmcid">PMC8981871</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>X</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cao</surname><given-names>C</given-names></name></person-group>. <article-title>A nomogram based on molecular biomarkers and radiomics to predict lymph node metastasis in breast cancer</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>790076</fpage>.<pub-id pub-id-type="pmid">35372007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.790076</pub-id><pub-id pub-id-type="pmcid">PMC8965370</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><name name-style="western"><surname>Spuhler</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI</article-title>. <source>J Magn Reson Imaging</source><year>2019</year>;<volume>49</volume>:<fpage>131</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="pmid">30171822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmri.26224</pub-id><pub-id pub-id-type="pmcid">PMC6298835</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer</article-title>. <source>Eur Radiol</source><year>2019</year>;<volume>29</volume>:<fpage>3820</fpage>&#8211;<lpage>29</lpage>.<pub-id pub-id-type="pmid">30701328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-018-5981-2</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Kong</surname><given-names>C</given-names></name><name name-style="western"><surname>Lin</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Development and validation of convolutional neural network-based model to predict the risk of sentinel or non-sentinel lymph node metastasis in patients with breast cancer: a machine learning study</article-title>. <source>eClinicalMedicine</source><year>2023</year>:<fpage>63</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2023.102176</pub-id><pub-id pub-id-type="pmcid">PMC10474371</pub-id><pub-id pub-id-type="pmid">37662514</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Deep learning radiomics of preoperative breast MRI for prediction of axillary lymph node metastasis in breast cancer</article-title>. <source>J Digital Imaging</source><year>2023</year>;<volume>36</volume>:<fpage>1323</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10278-023-00818-9</pub-id><pub-id pub-id-type="pmcid">PMC10042410</pub-id><pub-id pub-id-type="pmid">36973631</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name></person-group>. <article-title>Radiomic nomogram for predicting axillary lymph node metastasis in patients with breast cancer</article-title>. <source>Acad Radiol</source><year>2024</year>;<volume>31</volume>:<fpage>788</fpage>&#8211;<lpage>99</lpage>.<pub-id pub-id-type="pmid">37932165</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.acra.2023.10.026</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name></person-group>. <article-title>Machine-learning methods based on the texture and non-texture features of MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer</article-title>. <source>Transl Cancer Res</source><year>2023</year>;<volume>12</volume>:<fpage>3471</fpage>&#8211;<lpage>85</lpage>.<pub-id pub-id-type="pmid">38192975</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/tcr-22-2534</pub-id><pub-id pub-id-type="pmcid">PMC10774029</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ai</surname><given-names>T</given-names></name></person-group>. <article-title>A nomogram based on radiomics signature and deep-learning signature for preoperative prediction of axillary lymph node metastasis in breast cancer</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>940655</fpage>.<pub-id pub-id-type="pmid">36338691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.940655</pub-id><pub-id pub-id-type="pmcid">PMC9633001</pub-id></mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Mao</surname><given-names>N</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer</article-title>. <source>Cancer Imaging</source><year>2020</year>;<volume>20</volume>:<fpage>65</fpage>.<pub-id pub-id-type="pmid">32933585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40644-020-00342-x</pub-id><pub-id pub-id-type="pmcid">PMC7493182</pub-id></mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>1047572</fpage>.<pub-id pub-id-type="pmid">36578933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.1047572</pub-id><pub-id pub-id-type="pmcid">PMC9792138</pub-id></mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C</given-names></name><name name-style="western"><surname>Hao</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>O</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name></person-group>. <article-title>Radiomics-based signature of breast cancer on preoperative contrast-enhanced MRI to predict axillary metastasis</article-title>. <source>Future Oncol</source><year>2022</year>:<fpage>1</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2217/fon-2022-0333</pub-id><pub-id pub-id-type="pmid">36475996</pub-id></mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>M</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qin</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>A radiomics model for preoperative predicting sentinel lymph node metastasis in breast cancer based on dynamic contrast-enhanced MRI</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>884599</fpage>.<pub-id pub-id-type="pmid">35734587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.884599</pub-id><pub-id pub-id-type="pmcid">PMC9207247</pub-id></mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Preoperative prediction of axillary lymph node metastasis in breast cancer based on intratumoral and peritumoral DCE-MRI radiomics nomogram</article-title>. <source>Contrast Media &amp; Molecular Imaging</source><year>2022</year>;<volume>2022</volume>:<fpage>6729473</fpage>.<pub-id pub-id-type="pmid">36051932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/6729473</pub-id><pub-id pub-id-type="pmcid">PMC9410821</pub-id></mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Lan</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Development and validation of a radiogenomics model to predict axillary lymph node metastasis in breast cancer integrating MRI with transcriptome data: a multicohort study</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>1076267</fpage>.<pub-id pub-id-type="pmid">36644636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.1076267</pub-id><pub-id pub-id-type="pmcid">PMC9837803</pub-id></mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herg&#225;r</surname><given-names>L</given-names></name><name name-style="western"><surname>Kov&#225;cs</surname><given-names>N</given-names></name><name name-style="western"><surname>Ag&#243;cs</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>No evidence for the superiority of 3 Tesla magnetic resonance imaging over 1.5 Tesla magnetic resonance imaging for diagnosing wrist ligamentous lesions: a systematic review and meta-analysis</article-title>. <source>Arthroscopy</source><year>2024</year>;<volume>40</volume>:<fpage>2730</fpage>&#8211;<lpage>41.e10</lpage>.<pub-id pub-id-type="pmid">38735416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arthro.2024.04.029</pub-id></mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wardlaw</surname><given-names>JM</given-names></name><name name-style="western"><surname>Brindle</surname><given-names>W</given-names></name><name name-style="western"><surname>Casado</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>A systematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research</article-title>. <source>Eur Radiol</source><year>2012</year>;<volume>22</volume>:<fpage>2295</fpage>&#8211;<lpage>303</lpage>.<pub-id pub-id-type="pmid">22684343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-012-2500-8</pub-id></mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhe</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>The diagnostic performance of machine learning-based radiomics of DCE-MRI in predicting axillary lymph node metastasis in breast cancer: a meta-analysis</article-title>. <source>Front Oncol</source><year>2022</year>;<volume>12</volume>:<fpage>799209</fpage>.<pub-id pub-id-type="pmid">35186739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2022.799209</pub-id><pub-id pub-id-type="pmcid">PMC8854258</pub-id></mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Djilas-Ivanovic</surname><given-names>DD</given-names></name><name name-style="western"><surname>Prvulovic</surname><given-names>NP</given-names></name><name name-style="western"><surname>Bogdanovic-Stojanovic</surname><given-names>DD</given-names></name><etal/></person-group>. <article-title>Breast MRI: intraindividual comparative study at 1.5 and 3.0T; initial experience</article-title>. <source>J Buon</source><year>2012</year>;<volume>17</volume>:<fpage>65</fpage>&#8211;<lpage>72</lpage>.<pub-id pub-id-type="pmid">22517695</pub-id></mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dietzel</surname><given-names>M</given-names></name><name name-style="western"><surname>Wenkel</surname><given-names>E</given-names></name><name name-style="western"><surname>Hammon</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Does higher field strength translate into better diagnostic accuracy? A prospective comparison of breast MRI at 3 and 1.5 Tesla</article-title>. <source>Eur J Radiol</source><year>2019</year>;<volume>114</volume>:<fpage>51</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="pmid">31005176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejrad.2019.02.033</pub-id></mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wood</surname><given-names>R</given-names></name><name name-style="western"><surname>Bassett</surname><given-names>K</given-names></name><name name-style="western"><surname>Foerster</surname><given-names>T</given-names></name><name name-style="western"><surname>Spry</surname><given-names>C</given-names></name><name name-style="western"><surname>Tong</surname><given-names>L</given-names></name></person-group>. <article-title>1.5 Tesla magnetic resonance imaging scanners compared with 3.0 Tesla magnetic resonance imaging scanners: systematic review of clinical effectiveness</article-title>. <source>CADTH Technol Overv</source><year>2012</year>;<volume>2</volume>:<fpage>e2201</fpage>.<pub-id pub-id-type="pmid">23002376</pub-id><pub-id pub-id-type="pmcid">PMC3442613</pub-id></mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uematsu</surname><given-names>T</given-names></name><name name-style="western"><surname>Kasami</surname><given-names>M</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>S</given-names></name><name name-style="western"><surname>Igarashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Nasu</surname><given-names>H</given-names></name></person-group>. <article-title>Comparison of 3- and 1.5-T dynamic breast MRI for visualization of spiculated masses previously identified using mammography</article-title>. <source>Am J Roentgenol</source><year>2012</year>;<volume>198</volume>:<fpage>W611</fpage>&#8211;<lpage>W7</lpage>.<pub-id pub-id-type="pmid">22623579</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2214/AJR.11.7463</pub-id></mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vial</surname><given-names>A</given-names></name><name name-style="western"><surname>Stirling</surname><given-names>D</given-names></name><name name-style="western"><surname>Field</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The role of deep learning and radiomic feature extraction in cancer-specific predictive modelling: a review</article-title>. <source>Transl Cancer Res</source><year>2018</year>;<volume>7</volume>:<fpage>803</fpage>&#8211;<lpage>16</lpage>.</mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Traverso</surname><given-names>A</given-names></name><name name-style="western"><surname>Wee</surname><given-names>L</given-names></name><name name-style="western"><surname>Dekker</surname><given-names>A</given-names></name><name name-style="western"><surname>Gillies</surname><given-names>R</given-names></name></person-group>. <article-title>Repeatability and reproducibility of radiomic features: a systematic review</article-title>. <source>Int J Radiat Oncol Biol Phys</source><year>2018</year>;<volume>102</volume>:<fpage>1143</fpage>&#8211;<lpage>58</lpage>.<pub-id pub-id-type="pmid">30170872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijrobp.2018.05.053</pub-id><pub-id pub-id-type="pmcid">PMC6690209</pub-id></mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Welch</surname><given-names>ML</given-names></name><name name-style="western"><surname>McIntosh</surname><given-names>C</given-names></name><name name-style="western"><surname>Haibe-Kains</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Vulnerabilities of radiomic signature development: the need for safeguards</article-title>. <source>Radiother Oncol</source><year>2019</year>;<volume>130</volume>:<fpage>2</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">30416044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.radonc.2018.10.027</pub-id></mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>JE</given-names></name><name name-style="western"><surname>Park</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name></person-group>. <article-title>Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives</article-title>. <source>Korean J Radiol</source><year>2019</year>;<volume>20</volume>:<fpage>1124</fpage>&#8211;<lpage>37</lpage>.<pub-id pub-id-type="pmid">31270976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3348/kjr.2018.0070</pub-id><pub-id pub-id-type="pmcid">PMC6609433</pub-id></mixed-citation></ref><ref id="R50"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scialpi</surname><given-names>M</given-names></name><name name-style="western"><surname>Bianconi</surname><given-names>F</given-names></name><name name-style="western"><surname>Cantisani</surname><given-names>V</given-names></name><name name-style="western"><surname>Palumbo</surname><given-names>B</given-names></name></person-group>. <article-title>Radiomic machine learning: is it really a useful method for the characterization of prostate cancer?</article-title><source>Radiology</source><year>2019</year>;<volume>291</volume>:<fpage>269</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="pmid">30835185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.2019182940</pub-id></mixed-citation></ref><ref id="R51"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xi</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Guo</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XK</given-names></name><name name-style="western"><surname>Ping</surname><given-names>ZG</given-names></name></person-group>. <article-title>Application of LASSO and its extended method in variable selection of regression analysis</article-title>. <source>Zhonghua Yu Fang Yi Xue Za Zhi [Chinese J Preventive Med]</source><year>2023</year>;<volume>57</volume>:<fpage>107</fpage>&#8211;<lpage>11</lpage>.<pub-id pub-id-type="pmid">36655266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3760/cma.j.cn112150-20220117-00063</pub-id></mixed-citation></ref><ref id="R52"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name><name name-style="western"><surname>Feng</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Feng</surname><given-names>G</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name></person-group>. <article-title>Repeatability of radiomics studies in colorectal cancer: a systematic review</article-title>. <source>BMC Gastroenterol</source><year>2023</year>;<volume>23</volume>:<fpage>125</fpage>.<pub-id pub-id-type="pmid">37059990</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12876-023-02743-1</pub-id><pub-id pub-id-type="pmcid">PMC10105401</pub-id></mixed-citation></ref><ref id="R53"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>DM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>HT</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T</given-names></name></person-group>. <article-title>The application of radiomics in breast MRI: a review</article-title>. <source>Technol Cancer Res Treat</source><year>2020</year>;<volume>19</volume>:<fpage>1533033820916191</fpage>.<pub-id pub-id-type="pmid">32347167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1533033820916191</pub-id><pub-id pub-id-type="pmcid">PMC7225803</pub-id></mixed-citation></ref><ref id="R54"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da-Ano</surname><given-names>R</given-names></name><name name-style="western"><surname>Masson</surname><given-names>I</given-names></name><name name-style="western"><surname>Lucia</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies</article-title>. <source>Sci Rep</source><year>2020</year>;<volume>10</volume>:<fpage>10248</fpage>.<pub-id pub-id-type="pmid">32581221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-020-66110-w</pub-id><pub-id pub-id-type="pmcid">PMC7314795</pub-id></mixed-citation></ref><ref id="R55"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kruse</surname><given-names>CS</given-names></name><name name-style="western"><surname>Goswamy</surname><given-names>R</given-names></name><name name-style="western"><surname>Raval</surname><given-names>Y</given-names></name><name name-style="western"><surname>Marawi</surname><given-names>S</given-names></name></person-group>. <article-title>Challenges and opportunities of big data in health care: a systematic review</article-title>. <source>JMIR Med Inform</source><year>2016</year>;<volume>4</volume>:<fpage>e38</fpage>.<pub-id pub-id-type="pmid">27872036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/medinform.5359</pub-id><pub-id pub-id-type="pmcid">PMC5138448</pub-id></mixed-citation></ref><ref id="R56"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larson</surname><given-names>DB</given-names></name><name name-style="western"><surname>Towbin</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Pryor</surname><given-names>RM</given-names></name><name name-style="western"><surname>Donnelly</surname><given-names>LF</given-names></name></person-group>. <article-title>Improving consistency in radiology reporting through the use of department-wide standardized structured reporting</article-title>. <source>Radiology</source><year>2013</year>;<volume>267</volume>:<fpage>240</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="pmid">23329657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.12121502</pub-id></mixed-citation></ref><ref id="R57"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pereira</surname><given-names>S</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>A</given-names></name><name name-style="western"><surname>Alves</surname><given-names>V</given-names></name><name name-style="western"><surname>Silva</surname><given-names>CA</given-names></name></person-group>. <article-title>Brain tumor segmentation using convolutional neural networks in MRI images</article-title>. <source>IEEE Trans Med Imaging</source><year>2016</year>;<volume>35</volume>:<fpage>1240</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="pmid">26960222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TMI.2016.2538465</pub-id></mixed-citation></ref><ref id="R58"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moeskops</surname><given-names>P</given-names></name><name name-style="western"><surname>Viergever</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mendrik</surname><given-names>AM</given-names></name><name name-style="western"><surname>de Vries Ls</surname></name><name name-style="western"><surname>Benders</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Isgum</surname><given-names>I</given-names></name></person-group>. <article-title>Automatic segmentation of MR brain images with a convolutional neural network</article-title>. <source>IEEE Trans Med Imaging</source><year>2016</year>;<volume>35</volume>:<fpage>1252</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="pmid">27046893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TMI.2016.2548501</pub-id></mixed-citation></ref><ref id="R59"><label>[59]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>GS</given-names></name><name name-style="western"><surname>Moons</surname><given-names>KGM</given-names></name></person-group>. <article-title>Reporting of artificial intelligence prediction models</article-title>. <source>Lancet</source><year>2019</year>;<volume>393</volume>:<fpage>1577</fpage>&#8211;<lpage>79</lpage>.<pub-id pub-id-type="pmid">31007185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(19)30037-6</pub-id></mixed-citation></ref><ref id="R60"><label>[60]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarzhans</surname><given-names>F</given-names></name><name name-style="western"><surname>George</surname><given-names>G</given-names></name><name name-style="western"><surname>Escudero Sanchez</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Image normalization techniques and their effect on the robustness and predictive power of breast MRI radiomics</article-title>. <source>Eur J Radiol</source><year>2025</year>;<volume>187</volume>:<fpage>112086</fpage>.<pub-id pub-id-type="pmid">40184762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejrad.2025.112086</pub-id></mixed-citation></ref><ref id="R61"><label>[61]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pesapane</surname><given-names>F</given-names></name><name name-style="western"><surname>Rotili</surname><given-names>A</given-names></name><name name-style="western"><surname>Agazzi</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>Recent radiomics advancements in breast cancer: lessons and pitfalls for the next future</article-title>. <source>Curr Oncol</source><year>2021</year>;<volume>28</volume>:<fpage>2351</fpage>&#8211;<lpage>72</lpage>.<pub-id pub-id-type="pmid">34202321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/curroncol28040217</pub-id><pub-id pub-id-type="pmcid">PMC8293249</pub-id></mixed-citation></ref><ref id="R62"><label>[62]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savio</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>LC</given-names></name><name name-style="western"><surname>Luukkaala</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Effect of slice thickness on brain magnetic resonance image texture analysis</article-title>. <source>Biomed Eng Online</source><year>2010</year>;<volume>9</volume>:<fpage>60</fpage>.<pub-id pub-id-type="pmid">20955567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1475-925X-9-60</pub-id><pub-id pub-id-type="pmcid">PMC2970603</pub-id></mixed-citation></ref><ref id="R63"><label>[63]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ford</surname><given-names>J</given-names></name><name name-style="western"><surname>Dogan</surname><given-names>N</given-names></name><name name-style="western"><surname>Young</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name></person-group>. <article-title>Quantitative radiomics: impact of pulse sequence parameter selection on MRI-based textural features of the brain</article-title>. <source>Contrast Media &amp; Molecular Imaging</source><year>2018</year>;<volume>2018</volume>:<fpage>1729071</fpage>.<pub-id pub-id-type="pmid">30154684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2018/1729071</pub-id><pub-id pub-id-type="pmcid">PMC6091359</pub-id></mixed-citation></ref><ref id="R64"><label>[64]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schick</surname><given-names>U</given-names></name><name name-style="western"><surname>Lucia</surname><given-names>F</given-names></name><name name-style="western"><surname>Dissaux</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology</article-title>. <source>Br J Radiol</source><year>2019</year>;<volume>92</volume>:<fpage>20190105</fpage>.<pub-id pub-id-type="pmid">31538516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1259/bjr.20190105</pub-id><pub-id pub-id-type="pmcid">PMC6913356</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>